Pasar al contenido principal

PERFIL GENOMICO Y TRANSCRIPOMICO DE PACIENTES CON CANCER DE VEJIGA CON INVASION MUSCULAR TRATADOS CON QUIMIOTERAPIA NEOADYUVANTE: DESCUBRIMIENTO DE UNA SIGNATURA PARA PREDECIR LA RESPUESTA AL TRATAMIENTO

PI19/00004

•
Nombre agencia financiadora Instituto de Salud Carlos III
Acrónimo agencia financiadora ISCIII
Programa Programa Estatal de Generación de Conocimiento y Fortalecimiento del Sistema Español de I+D+I
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de Investigación en Salud
Año convocatoria 2019
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACION INSTITUTO HOSPITAL DEL MAR DE INVESTIGACIONES MEDICAS (FIMIM)
Centro realización INSTITUTO HOSPITAL DEL MAR DE INVESTIGACIONES MEDICAS (IMIM)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Elevated α-Ketoglutaric Acid Concentrations and a Lipid-Balanced Signature Are the Key Factors in Long-Term HIV Control

  • Masip, Jenifer|||0000-0002-9233-5195
  • Rallón, Norma|||0000-0002-4643-247X
  • Yeregui, Elena|||0000-0003-2994-4219
  • Olona, Montserrat|||0000-0001-5303-9361
  • Resino, Salvador|||0000-0001-8783-0450
  • Benito, José Miguel|||0000-0002-7172-049X
  • Viladés, Consuelo|||0000-0002-2991-9593
  • García-Pardo, Graciano|||0000-0003-0274-6001
  • Alcami, Jose|||0000-0003-0023-7377
  • Ruiz-Mateos, Ezequiel|||0000-0001-6747-7813
  • Gómez-Bertomeu, Frederic
  • Vargas Laguna, Montserrat|||0000-0001-7650-0587
  • Navarro Vilasaro, Marta|||0000-0002-3784-4405
  • Oteo, José A.|||0000-0001-7080-6542
  • Pineda, Juan A.|||0000-0002-3751-0296
  • Martí, Anna
  • Alba, Verónica|||0000-0002-5925-9573
  • Vidal, Francesc|||0000-0002-6692-6186
  • Peraire, Joaquim|||0000-0001-7808-5479
  • Rull, Anna|||0000-0002-8907-7754
Long-term elite controllers (LTECs) are a fascinating small subset of HIV individuals with viral and immunological HIV control in the long term that have been designated as models of an HIV functional cure. However, data on the LTEC phenotype are still scarce, and hence, the metabolomics and lipidomics signatures in the LTEC-extreme phenotype, LTECs with more than 10 years of viral and immunological HIV control, could be pivotal to finding the keys for functional HIV remission. Metabolomics and lipidomics analyses were performed using high-resolution mass spectrometry (ultra-high-performance liquid chromatography-electrospray ionization-quadrupole time of flight [UHPLC-(ESI) qTOF] in plasma samples of 13 patients defined as LTEC-extreme, a group of 20 LTECs that lost viral and/or immunological control during the follow-up study (LTEC-losing) and 9 EC patients with short-term viral and immunological control (less than 5 years; no-LTEC patients). Long-term viral and immunological HIV-1 control was found to be strongly associated with elevated tricarboxylic acid (TCA) cycle function. Interestingly, of the nine metabolites identified in the TCA cycle, α-ketoglutaric acid (p = 0.004), a metabolite implicated in the activation of the mTOR complex, a modulator of HIV latency and regulator of several biological processes, was found to be a key metabolite in the persistent control. On the other hand, a lipidomics panel combining 45 lipid species showed an optimal percentage of separation and an ability to differentiate LTEC-extreme from LTEC-losing, revealing that an elevated lipidomics plasma profile could be a predictive factor for the reignition of viral replication in LTEC individuals.